Вакцина от меланомы снизила риск рецидива на 42%: результаты крупного исследования
Вакцина от меланомы снизила риск рецидива на 42%: результаты крупного исследования Газета Балаково
Вакцина от меланомы снизила риск рецидива на 42%: результаты крупного исследования Газета Балаково
Personalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial NBC News
В зоне риска? Кому из женщин нужно срочно бежать к онкологу и не откладывать визит на потом ФОНТАНКА.ру
Blood Cancer Drug Denials; Body Fat and Pancreas Cancer; Studies With Fake Citations MedPage Today
Cathy Eng: AACR Conference Spotlights Early-Onset Cancer Oncodaily
Herbert Loong Joins Global Experts for Key Oncology Insights at ESMO 2026 Oncodaily
Joanna Metzner-Sadurski Advances Cancer Care Access for Rural Communities at ACCC 2026 Oncodaily
A new analysis of a phase 3 clinical trial found that the targeted drug daraxonrasib improved survival compared with standard chemotherapy across multiple groups of patients with advanced pancreatic cancer, including those with different RAS mutations and those without an identified RAS mutation.
The activity of six different genes can help determine survival in patients with acute myeloid leukemia (AML), according to a study published in Science Advances. The findings by researchers at the Center for Genomic Regulation (CRG) in Barcelona lay the foundations for new ways of predicting how patients will fare…
Scientists at Trinity College Dublin have made a breakthrough in understanding how cancer cells can evade the cell-killing effects of chemotherapy and enter a "zombie-like state," called premature senescence, that can attract the wound-healing properties of the immune system.
How Israeli Researchers Are Using AI To Transform Cancer Treatment and Diagnoses Baltimore Jewish Times
Reversing radiation-activated immune suppression in cancer UChicago Medicine
What if we could use a cancer's own byproduct to make drugs that destroy tumor cells from the inside? That is what Katsunori Tanaka and his team have done at the RIKEN Pioneering Research Institute (PRI) in Japan.
ИИ научился определять риск рака через популярное фото - исследование Cursorinfo
ИИ научился определять риск рака через популярное фото - исследование Cursorinfo